section name header

Basics

Ruth Ann Baird, MD

Joanne M. Wojcieszek, MD


BASICS

DESCRIPTION navigator

Hemiballismus is a hyperkinetic movement disorder characterized by violent flailing movements involving proximal limbs on one side of the body. Hemiballismus is considered an extreme form of chorea because as ballistic movements subside with time, they have the appearance of classic chorea.

EPIDEMIOLOGY

Incidence navigator

Prevalence navigator

RISK FACTORS navigator

Vascular risk factors, especially hypertension, are most important because stroke is the main cause of hemiballismus.

Genetics navigator

Patients of East Asian origin may be at increased risk for hemiballism due to hyperglycemia.

GENERAL PREVENTION navigator

Because stroke is the most common cause of hemiballismus, prevention would involve treatment of vascular risk factors (i.e. hypertension, diabetes, tobacco use).

PATHOPHYSIOLOGY navigator

Damage to the subthalamic nucleus or surrounding pathways leads to loss of normal subthalamic inhibition, which results in abnormal involuntary movements on the contralateral body. Hemiballismus may also result from pathology within the globus pallidus, thalamus, substantia nigra, putamen, or caudate.

ETIOLOGY navigator

Pregnancy Considerations navigator

There is no specific relationship with pregnancy except that chorea gravidarum occasionally can be severe and unilateral.

Pediatric Considerations navigator

Hemiballismus is rare in children; however, Sydenham's chorea can be unilateral and of such large amplitude to resemble hemiballismus. Hemiballistic limb movements have been reported in pediatric patients with ifosfamide-induced encephalopathy (2)[C].

COMMONLY ASSOCIATED CONDITIONS navigator


[Outline]

Diagnosis

DIAGNOSIS

HISTORY navigator

PHYSICAL EXAM navigator

DIAGNOSTIC TESTS AND INTERPRETATION

Lab

Initial Lab Tests navigator

Follow-Up & Special Considerations navigator

Imaging

Initial Approach navigator

Brain MRI or CT +/– contrast should be performed to search for a structural cause of hemiballismus.

Follow-Up & Special Considerations navigator

Brain MRI in acute stages of hemiballism due to nonketotic hyperglycemia may show T1 hyperintensity in the contralateral striatum (3)[C].

Diagnostic Procedures/Other navigator

No special procedures are required for diagnosis.

DIFFERENTIAL DIAGNOSIS navigator


[Outline]

Treatment

TREATMENT

MEDICATION

First Line

Neuroleptics navigator

These drugs are the first-line treatment for ballistic movements because of their proven efficacy. Antagonism of the postsynaptic D2 dopamine receptor seems to be the common feature among agents effective in the treatment of hemiballismus. Chlorpromazine, promethazine, perphenazine, prochlorperazine, haloperidol, pimozide, and tiapride, among other neuroleptics, have been shown to be effective in the treatment of hemiballismus. Clozapine in low doses (50 mg/day) also is useful. Response usually is dramatic and starts within 2 days and almost always within 7 days. If treatment is prolonged or there are side effects, consider using a benzodiazepine, a dopamine-depleting agent (e.g., reserpine, tetrabenazine), or a GABA-ergic agent such as valproate.

Second Line navigator

ADDITIONAL TREATMENT

General Measures navigator

Management requires identification of the cause of hemiballismus, mainly focusing on neuroimaging and identifying and treating risk factors, with special emphasis on vascular risk factors.

Issues for Referral navigator

Patients should follow-up with a neurologist.

Additional Therapies navigator

Botulinum toxin injections may be effective in decreasing amplitude of movements (4)[C].

SURGERY/OTHER PROCEDURES navigator

IN-PATIENT CONSIDERATIONS

Initial Stabilization navigator

Ensure stable cardiorespiratory status

Admission Criteria navigator

All patients should be admitted for diagnostic evaluation and started on treatment for the ballismus.

IV Fluids navigator

Normal saline should be administered to prevent dehydration.

Nursing navigator

Padding of the limb and bedrails may be necessary to prevent injury.

Discharge Criteria navigator

Discharge criteria and workup depend on the underlying diagnosis.


[Outline]

Ongoing Care

ONGOING-CARE

FOLLOW-UP RECOMMENDATIONS navigator

Patient Monitoring navigator

DIET navigator

Varies according to underlying diagnosis

PATIENT EDUCATION navigator

There are no support groups or organizations providing information for patients with hemiballismus. The condition is mentioned briefly at www.wemove.org.

PROGNOSIS navigator

COMPLICATIONS navigator

Severely affected patients may experience medical complications of excessive movement such as dehydration or rhabdomyolysis. Supportive care directed at preventing complications of hospitalization, such as aspiration pneumonia, pulmonary embolism, and urinary tract infection, should be provided.


[Outline]

Codes

CODES

ICD9

333.5 Other choreas

Clinical Pearls

Stroke is the cause of hemiballismus in a majority of cases.

References

  1. Dewey RB, Jankovic J. Hemiballism-hemichorea: clinical and pharmacologic findings in 21 patients. Arch Neurol 1989;46:862–867.
  2. Ames B, Lewis LD, Chaffee S, et al. Ifosfamide-induced encephalopathy and movement disorder. Pediatr Blood Cancer 2010;54:624–626.
  3. Yahikozawa H, Hanyu N, Yamamoto K, et al. Hemiballism with striatal hyperintensity on T1-weighted MRI in diabetes patients; a unique syndrome. J Neurol Sci 1994;124:208–214.
  4. Dressler D, Wittstock M, Benecke R. Treatment of persistent hemiballism with botulinum toxin type A. Mov Dis 2000;15:1281–1282.
  5. Tsubokawa T, Katayama Y, Yamamoto T. Control of persistent hemiballismus by chronic thalamic stimulation. J Neurosurg 1995;82:501–505.
  6. Hasegawa H, Mundil N, Samuel M, et al. The treatment of persistent vascular hemidystonia–hemiballismus with unilateral GPi deep brain stimulation. Mov Dis 2009;24:1697.

SEE-ALSO